Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3985520
Max Phase: Preclinical
Molecular Formula: C46H50ClN5O8S
Molecular Weight: 868.45
Molecule Type: Small molecule
Associated Items:
ID: ALA3985520
Max Phase: Preclinical
Molecular Formula: C46H50ClN5O8S
Molecular Weight: 868.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cccc5[nH]ccc45)c3)CC2)=C(c2ccc(Cl)cc2)C1
Standard InChI: InChI=1S/C46H50ClN5O8S/c1-46(2)18-14-33(39(28-46)32-6-8-34(47)9-7-32)29-50-20-22-51(23-21-50)35-10-12-38(44(26-35)60-42-5-3-4-40-37(42)15-19-48-40)45(53)49-61(56,57)36-11-13-43(41(27-36)52(54)55)59-30-31-16-24-58-25-17-31/h3-13,15,19,26-27,31,48H,14,16-18,20-25,28-30H2,1-2H3,(H,49,53)
Standard InChI Key: ORKPNCUVXKYCRR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 868.45 | Molecular Weight (Monoisotopic): 867.3069 | AlogP: 9.23 | #Rotatable Bonds: 13 |
Polar Surface Area: 156.34 | Molecular Species: ACID | HBA: 10 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.17 | CX Basic pKa: 7.96 | CX LogP: 7.33 | CX LogD: 7.45 |
Aromatic Rings: 5 | Heavy Atoms: 61 | QED Weighted: 0.09 | Np Likeness Score: -0.93 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):